The pituitary tumor transforming gene 1 (PTTG-1): An immunological target for multiple myeloma

被引：0
|
作者：
Maurizio Chiriva-Internati
Raffaele Ferrari
Madhavi Prabhakar
Yuefei Yu
Luigi Baglioni
Jorge Moreno
Nicoletta Gagliano
Nicola Portinaro
Marjorie R Jenkins
Eldo E Frezza
Fred Hardwicke
Nicholas D'Cunha
W Martin Kast
Everardo Cobos
机构：
[1] Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center,Department of Microbiology and Immunology
[2] Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center,Division of Hematology and Oncology
[3] Texas Tech University Health Sciences Center and Southwest Texas Tech University Health Sciences Center and Southwest Cancer Treatment and Research Center,Division of Surgery
[4] University of Milan,Department of Human Morphology
[5] Obstetrics & Gynecology and Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine,Department of Internal Medicine
[6] Texas Tech University Health Sciences Center,Department of Pediatric Orthopedic Surgery
[7] Istituto Clinico Humanitas,Department of Molecular Microbiology & Immunology and Obstetrics & Gynecology, Norris Comprehensive Cancer Center
[8] University of Southern California,undefined
来源：
Journal of Translational Medicine | / 6卷
关键词：
Multiple Myeloma; Fluorescence Activate Cell Sorter; Human Normal Tissue; Multiple Myeloma Patient; Chronic Myelogenous Leukemia Cell Line;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Is complement C1q a potential marker for tumor burden and immunodeficiency in multiple myeloma?
    Yang, Ronghui
    Huang, Jin
    Ma, Huanxin
    Li, Shiwen
    Gao, Xin
    Liu, Yingshu
    Shen, Jing
    Liao, Aijun
    LEUKEMIA & LYMPHOMA, 2019, 60 (07) : 1812 - 1818
  • [42] Role of BACH1 in multiple myeloma
    Chen, Yan
    Zeng, Zhiyong
    Chen, Junmin
    HEMATOLOGY, 2024, 29 (01)
  • [43] The significance of RB1 in multiple myeloma
    Wang, Yiwen
    Yang, Rui
    Liu, Rui
    Yang, Ruoyu
    Lin, Zujie
    He, Aili
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [44] Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
    Tremblay-LeMay, Rosemarie
    Rastgoo, Nasrin
    Chang, Hong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [45] CS1, a SLAM family receptor involved in immune regulation, is a therapeutic target in multiple myeloma
    Veillette, Andre
    Guo, Huaijian
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 88 (01) : 168 - 177
  • [46] AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma
    Gu, Chunyan
    Wang, Yajun
    Zhang, Lulin
    Qiao, Li
    Sun, Shanliang
    Shao, Miaomiao
    Tang, Xiaozhu
    Ding, Pinggang
    Tang, Chao
    Cao, Yuhao
    Zhou, Yanyan
    Guo, Mengjie
    Wei, Rongfang
    Li, Nianguang
    Xiao, Yibei
    Duan, Jinao
    Yang, Ye
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [47] Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma
    Yousef, Sara
    Heise, Johanna
    Lajmi, Nesrine
    Bartels, Katrin
    Kroeger, Nicolaus
    Luetkens, Tim
    Atanackovic, Djordje
    JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
  • [48] Modulating PD-L1 expression in multiple myeloma: an alternative strategy to target the PD-1/PD-L1 pathway
    Rosemarie Tremblay-LeMay
    Nasrin Rastgoo
    Hong Chang
    Journal of Hematology & Oncology, 11
  • [49] P-Selectin Glycoprotein Ligand-1 as a Potential Target for Humoral Immunotherapy of Multiple Myeloma
    Tripodo, C.
    Florena, A. M.
    Macor, P.
    Di Bernardo, A.
    Porcasi, R.
    Guarnotta, C.
    Ingrao, S.
    Zerilli, M.
    Secco, E.
    Todaro, M.
    Tedesco, F.
    Franco, V.
    CURRENT CANCER DRUG TARGETS, 2009, 9 (05) : 617 - 625
  • [50] AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma
    Chunyan Gu
    Yajun Wang
    Lulin Zhang
    Li Qiao
    Shanliang Sun
    Miaomiao Shao
    Xiaozhu Tang
    Pinggang Ding
    Chao Tang
    Yuhao Cao
    Yanyan Zhou
    Mengjie Guo
    Rongfang Wei
    Nianguang Li
    Yibei Xiao
    Jinao Duan
    Ye Yang
    Journal of Experimental & Clinical Cancer Research, 41
12345